[Clinical results of a new antiphlogistically effective substance, Azapropazon].
D000700:Analgesics / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use; D004357:Drug Synergism; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy*; D008134:Long-Term Care; D011239:Prednisolone / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D011720:Pyrazoles; D011239:Prednisolone
Klinische Ergebnisse mit der neuen antiphlogistisch wirkenden Substanz Azapropazon.